102 related articles for article (PubMed ID: 12430883)
1. The importance of lowering the costs of stem cell transplantation in developing countries.
Barr RD
Int J Hematol; 2002 Aug; 76 Suppl 1():365-7. PubMed ID: 12430883
[TBL] [Abstract][Full Text] [Related]
2. The simplification of the SCT procedures in developing countries has resulted in cost-lowering and availability to more patients.
Gómez-Almaguer D
Int J Hematol; 2002 Aug; 76 Suppl 1():380-2. PubMed ID: 12430886
[TBL] [Abstract][Full Text] [Related]
3. Societal value of stem cell therapy in stroke--a modeling study.
Svensson J; Ghatnekar O; Lindgren A; Lindvall O; Norrving B; Persson U; Kokaia Z
Cerebrovasc Dis; 2012; 33(6):532-9. PubMed ID: 22571941
[TBL] [Abstract][Full Text] [Related]
4. An economic evaluation of early versus delayed operative treatment in patients with closed tibial shaft fractures.
Sprague S; Bhandari M
Arch Orthop Trauma Surg; 2002 Jul; 122(6):315-23. PubMed ID: 12136294
[TBL] [Abstract][Full Text] [Related]
5. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
6. Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning.
Suh KJ; Kim I; Lim J; Ha H; Park S; Koh Y; Yoon SS; Park S
Clin Transplant; 2015 Feb; 29(2):124-33. PubMed ID: 25430486
[TBL] [Abstract][Full Text] [Related]
7. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of treatments for cancer in childhood.
Barr RD; Feeny D; Furlong W
Eur J Cancer; 2004 Jun; 40(9):1335-45. PubMed ID: 15177493
[TBL] [Abstract][Full Text] [Related]
9. Saving lives and saving money: hospital-based violence intervention is cost-effective.
Juillard C; Smith R; Anaya N; Garcia A; Kahn JG; Dicker RA
J Trauma Acute Care Surg; 2015 Feb; 78(2):252-7; discussion 257-8. PubMed ID: 25757108
[TBL] [Abstract][Full Text] [Related]
10. A Mexican way to cope with stem cell grafting.
Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Hematology; 2012 Apr; 17 Suppl 1():S195-7. PubMed ID: 22507819
[TBL] [Abstract][Full Text] [Related]
11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
Perrier L; Lefranc A; Pérol D; Quittet P; Schmidt-Tanguy A; Siani C; de Peretti C; Favier B; Biron P; Moreau P; Bay JO; Lissandre S; Jardin F; Espinouse D; Sebban C
Appl Health Econ Health Policy; 2013 Apr; 11(2):129-38. PubMed ID: 23435861
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC).
Bredeson C; Malcolm J; Davis M; Bence-Bruckler I; Kearns B; Huebsch L
Bone Marrow Transplant; 1997 Nov; 20(10):889-96. PubMed ID: 9404932
[TBL] [Abstract][Full Text] [Related]
14. Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation.
Bennett C; Waters T; Stinson T; Almagor O; Pavletic Z; Tarantolo S; Bishop M
Bone Marrow Transplant; 1999 Sep; 24(5):555-60. PubMed ID: 10482942
[TBL] [Abstract][Full Text] [Related]
15. Cost comparative study of autologous peripheral blood progenitor cells (PBPC) and bone marrow (ABM) transplantations for non-Hodgkin's lymphoma patients.
Woronoff-Lemsi MC; Arveux P; Limat S; Deconinck E; Morel P; Cahn JY
Bone Marrow Transplant; 1997 Dec; 20(11):975-82. PubMed ID: 9422478
[TBL] [Abstract][Full Text] [Related]
16. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
[TBL] [Abstract][Full Text] [Related]
17. Dedicated Perioperative Hip Fracture Comanagement Programs are Cost-effective in High-volume Centers: An Economic Analysis.
Swart E; Vasudeva E; Makhni EC; Macaulay W; Bozic KJ
Clin Orthop Relat Res; 2016 Jan; 474(1):222-33. PubMed ID: 26260393
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis associated low-back and leg pain over two years.
Parker SL; Adogwa O; Bydon A; Cheng J; McGirt MJ
World Neurosurg; 2012 Jul; 78(1-2):178-84. PubMed ID: 22120269
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
